BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gwee KA, Ghoshal UC, Chen M. Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management. J Gastroenterol Hepatol 2018;33:99-110. [PMID: 28901578 DOI: 10.1111/jgh.13987] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Guo J, Lu G, Chen L, Geng H, Wu X, Chen H, Li Y, Yuan M, Sun J, Pei L. Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome. Acupunct Med 2021;:9645284211027892. [PMID: 34231397 DOI: 10.1177/09645284211027892] [Reference Citation Analysis]
2 Wang Y, Dong Y, Wang E, Meng Y, Bi Z, Sun S, Zhang C, Fan H, Yuan J. Shugan Decoction Alleviates Colonic Dysmotility in Female SERT-Knockout Rats by Decreasing M3 Receptor Expression. Front Pharmacol 2020;11:01082. [PMID: 33013355 DOI: 10.3389/fphar.2020.01082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhuang X, Tian Z, Luo M, Xiong L. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol 2020;20:187. [PMID: 32532214 DOI: 10.1186/s12876-020-01336-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ji L, Zhao X, Zhang Y, Zhao P, Gong R, Li F, Huang H. Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial. Medicine (Baltimore) 2022;101:e28895. [PMID: 35244043 DOI: 10.1097/MD.0000000000028895] [Reference Citation Analysis]
5 Park J, Lee D, Kwon SH, Song JY, Baek YS, Jeon J. A Pilot Study about Possible Gluten Sensitivity in Korean Urticaria Patients. Ann Dermatol 2019;31:585-8. [PMID: 33911655 DOI: 10.5021/ad.2019.31.5.585] [Reference Citation Analysis]
6 Alharbi W, Jahan S. Prevalence and Associated Risk Factors of Irritable Bowel Syndrome Among Female Secondary School students in Ar Rass City, Qassim Region. Health Psychology Research 2022;10. [DOI: 10.52965/001c.35482] [Reference Citation Analysis]
7 Yuan F, Tan W, Ren H, Yan L, Wang Y, Luo H. The Effects of Short-Chain Fatty Acids on Rat Colonic Hypermotility Induced by Water Avoidance Stress. Drug Des Devel Ther 2020;14:4671-84. [PMID: 33173277 DOI: 10.2147/DDDT.S246619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Pietrzak A, Skrzydło-Radomańska B, Mulak A, Lipiński M, Małecka-Panas E, Reguła J, Rydzewska G. Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik. Prz Gastroenterol 2018;13:259-88. [PMID: 30581501 DOI: 10.5114/pg.2018.78343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Vatn SS, Lindstrøm JC, Moen AE, Brackmann S, Tannæs TM, Olbjørn C, Bergemalm D, Keita ÅV, Gomollon F, Detlie TE, Lüders T, Kalla R, Adams A, Satsangi J, Jahnsen J, Vatn MH, Halfvarson J, Ricanek P, Nilsen H. Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort. CEG 2022;Volume 15:5-25. [DOI: 10.2147/ceg.s343468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang J, Wang Y, Zhou H, Gu W, Wang X, Yang J. Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea. Eur J Gastroenterol Hepatol 2020;32:706-12. [PMID: 32317585 DOI: 10.1097/MEG.0000000000001737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Pei L, Geng H, Guo J, Yang G, Wang L, Shen R, Xia S, Ding M, Feng H, Lu J, Li J, Liu L, Shu Y, Fang X, Wu X, Wang X, Weng S, Ju L, Chen X, Shen H, Sun J. Effect of Acupuncture in Patients With Irritable Bowel Syndrome: A Randomized Controlled Trial. Mayo Clin Proc 2020;95:1671-83. [PMID: 32499125 DOI: 10.1016/j.mayocp.2020.01.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
12 Yao C, Li Y, Luo L, Xie F, Xiong Q, Li T, Yang C, Feng PM. Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China. Dig Dis Sci 2022. [PMID: 35503487 DOI: 10.1007/s10620-022-07500-0] [Reference Citation Analysis]
13 Chen HB, Su XY. Efficacy and safety of lactulose for the treatment of irritable bowel syndrome. Medicine (Baltimore) 2019;98:e17295. [PMID: 31574851 DOI: 10.1097/MD.0000000000017295] [Reference Citation Analysis]
14 Creed F. Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies. Aliment Pharmacol Ther 2019;50:507-16. [DOI: 10.1111/apt.15396] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
15 Li X, Li B, Zhang J, Chen T, Wu H, Shi X, Ma J, Qin J, Tang X, Wang F. Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24361. [PMID: 33530231 DOI: 10.1097/MD.0000000000024361] [Reference Citation Analysis]
16 Takajo T, Tomita K, Tsuchihashi H, Enomoto S, Tanichi M, Toda H, Okada Y, Furuhashi H, Sugihara N, Wada A, Horiuchi K, Inaba K, Hanawa Y, Shibuya N, Shirakabe K, Higashiyama M, Kurihara C, Watanabe C, Komoto S, Nagao S, Kimura K, Miura S, Shimizu K, Hokari R. Depression Promotes the Onset of Irritable Bowel Syndrome through Unique Dysbiosis in Rats. Gut Liver 2019;13:325-32. [PMID: 30602220 DOI: 10.5009/gnl18296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
17 Liu Y, Xiao W, Yu L, Tian F, Wang G, Lu W, Narbad A, Chen W, Zhai Q. Evidence from comparative genomic analyses indicating that Lactobacillus-mediated irritable bowel syndrome alleviation is mediated by conjugated linoleic acid synthesis. Food Funct 2021;12:1121-34. [PMID: 33427835 DOI: 10.1039/d0fo02616f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ghoshal UC. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment. J Gastroenterol Hepatol 2020;35:712-21. [PMID: 32162356 DOI: 10.1111/jgh.15032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
19 Axelrod CH, Saps M. Global Dietary Patterns and Functional Gastrointestinal Disorders. Children (Basel) 2020;7:E152. [PMID: 32992448 DOI: 10.3390/children7100152] [Reference Citation Analysis]
20 Bor S, Lehert P, Chalbaud A, Tack J. Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Therap Adv Gastroenterol 2021;14:17562848211033740. [PMID: 34539813 DOI: 10.1177/17562848211033740] [Reference Citation Analysis]
21 Rastgoo S, Ebrahimi-Daryani N, Agah S, Karimi S, Taher M, Rashidkhani B, Hejazi E, Mohseni F, Ahmadzadeh M, Sadeghi A, Hekmatdoost A. Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management. Front Nutr 2021;8:746703. [PMID: 34977110 DOI: 10.3389/fnut.2021.746703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Nahar L, Paul S, Chattopadhyay A, Koley M, Saha S. An open-label randomized pragmatic non-inferiority pilot trial to compare the effectiveness of Dysentery compound with individualized homeopathic medicines in irritable bowel syndrome. J Complement Integr Med 2019;16:/j/jcim. [PMID: 31199766 DOI: 10.1515/jcim-2018-0217] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol 2020;17:473-86. [DOI: 10.1038/s41575-020-0286-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 41.5] [Reference Citation Analysis]
24 Zhang Y, Ma ZF, Zhang H, Pan B, Li Y, Majid HA, Lee YY. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia. JGH Open 2019;3:173-8. [PMID: 31061894 DOI: 10.1002/jgh3.12125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Chuah KH, Mahadeva S. The challenges of implementing evidence-based therapy for irritable bowel syndrome in Asia. JGH Open 2021;5:1225-6. [PMID: 34816007 DOI: 10.1002/jgh3.12665] [Reference Citation Analysis]
26 Zielińska A, Sałaga M, Włodarczyk M, Fichna J. Chronic abdominal pain in irritable bowel syndrome - current and future therapies. Expert Rev Clin Pharmacol 2018;11:729-39. [PMID: 29957084 DOI: 10.1080/17512433.2018.1494571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Shi SM, Wen YL, Hou HB, Liu HX. Effectiveness of vitamin D for irritable bowel syndrome: A protocol for a systematic review of randomized controlled trial. Medicine (Baltimore) 2019;98:e14723. [PMID: 30817618 DOI: 10.1097/MD.0000000000014723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
28 Jia W, Liang H, Wang L, Sun M, Xie X, Gao J, Li L, Tang X, Ma Y. Associations between Abnormal Eating Styles and Irritable Bowel Syndrome: A Cross-Sectional Study among Medical School Students. Nutrients 2022;14:2828. [PMID: 35889787 DOI: 10.3390/nu14142828] [Reference Citation Analysis]
29 Yang Q, Wei ZC, Liu N, Pan YL, Jiang XS, Tantai XX, Yang Q, Yang J, Wang JJ, Shang L, Lin Q, Xiao CL, Wang JH. Predictive value of alarm symptoms in Rome IV irritable bowel syndrome: A multicenter cross-sectional study. World J Clin Cases 2022; 10(2): 563-575 [DOI: 10.12998/wjcc.v10.i2.563] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lin MJ, Yu BP. Upregulation of the high-affinity choline transporter in colon relieves stress-induced hyperalgesia. J Pain Res 2018;11:1971-82. [PMID: 30288092 DOI: 10.2147/JPR.S164186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Saadati S, Sadeghi A, Mohaghegh-Shalmani H, Rostami-Nejad M, Elli L, Asadzadeh-Aghdaei H, Rodrigo L, Zali MR. Effects of a gluten challenge in patients with irritable bowel syndrome: a randomized single-blind controlled clinical trial. Sci Rep 2022;12:4960. [PMID: 35322144 DOI: 10.1038/s41598-022-09055-6] [Reference Citation Analysis]
32 Sun JW, Sun ML, Li D, Zhao J, Shi SH, Li HX, Liu HM, Gao JX, Hu Y, Zheng H, Wang X, Xue RD, Feng X, Yu SG, Li ZG. Efficacy of acupuncture based on acupoint combination theory for irritable bowel syndrome: a study protocol for a multicenter randomized controlled trial. Trials 2021;22:719. [PMID: 34666815 DOI: 10.1186/s13063-021-05432-0] [Reference Citation Analysis]
33 Gwee KA, Gonlachanvit S, Ghoshal UC, Chua ASB, Miwa H, Wu J, Bak YT, Lee OY, Lu CL, Park H, Chen M, Syam AF, Abraham P, Sollano J, Chang CS, Suzuki H, Fang X, Fukudo S, Choi MG, Hou X, Hongo M. Second Asian Consensus on Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2019;25:343-362. [PMID: 31327218 DOI: 10.5056/jnm19041] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
34 Guo J, Yang L, He J, Yang Z. Comparison of therapeutic effects of different acupuncture and moxibustion therapies on irritable bowel syndrome: A protocol for systematic review and network meta-analysis. Medicine (Baltimore) 2021;100:e26920. [PMID: 34477123 DOI: 10.1097/MD.0000000000026920] [Reference Citation Analysis]